Infections with have been described in the literature over the last 2 decades, with the majority being bacteremia, central line infections, and occasionally, endocarditis. In recent years, the frequency of infections appears to be increasing; a factor likely contributing to this is the increased ease and accuracy of the identification of spp., including, from clinical cultures. The objective of this study was to retrospectively characterize isolates recovered from specimens submitted as part of routine patient care at a 1,250-bed, tertiary-care academic medical center. Multiple strain types were recovered, as demonstrated by repetitive-sequence-based PCR. Most of the strains of characterized were resistant to antimicrobials commonly used to treat Gram-positive organisms, such as penicillin, ceftriaxone, meropenem, clindamycin, and tetracycline. The MIC for ceftaroline was >32 μg/ml. Although there are no interpretive criteria for susceptibility with telavancin, it appeared to have potent efficacy against this species, with MIC and MIC values of 0.064 and 0.125 μg/ml, respectively. Finally, as previously reported in case studies, we demonstrated rapid development of daptomycin resistance in 100% of the isolates tested ( = 50), indicating that caution should be exhibited when using daptomycin for the treatment of infections. is an emerging, multidrug-resistant pathogen that can be associated with a variety of infection types.